Patents

US 12673952 B2: Processes for preparing modulators of alpha-1 antitrypsin

Granted
2026-07-07
Filed
2021-07-26 application 18018245
Type
Utility · 5 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

This disclosure provides large-scale processes for preparing a modulator of alpha-1 antitrypsin (AAT) activity that may be useful for treating alpha-1 antitrypsin deficiency (AATD), such as 4-(5-(4-fluorophenyl)-6-(tetrahydro-2H-pyran-4-yl)-1,5-dihydropyrrolo[2,3-f]indazol-7-yl)benzoic acid (Compound 1), 3-[5-(4-fluorophenyl)-6-isopropyl-1H-pyrrolo[2,3-f]indazol-7-yl]propanoic acid (Compound 2), or a pharmaceutically acceptable salt of any of the foregoing.

Source: PTBLXML, file of 2026-07-07 (ipgb20260707.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
Vertex Pharmaceuticals Incorporated 764 patentsUS company or organizationBoston, MAPTBLXML, file of 2026-07-07

Inventors

InventorPlacePatentsPerson pageSource
Cavan McKeon BlighMelrose, MA5PTBLXML, file of 2026-07-07
Robert Daniel GiacomettiMalden, MA3PTBLXML, file of 2026-07-07
Cristian HarrisonBeverly, MA10PTBLXML, file of 2026-07-07
Stephen W. LawsDorchester, MAPTBLXML, file of 2026-07-07
Adam LookerNewtonville, MA25PTBLXML, file of 2026-07-07
Stefanie RoeperMedford, MA20PTBLXML, file of 2026-07-07

CPC categories

SubclassCategoryFirst groupSource
C07DHeterocyclic compoundsC07D487/04PTBLXML, file of 2026-07-07

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

RecordedWhatFromToReel/frameSource
2023-12-28Assignment
Assignment of assignor's interest
ROEPER, STEFANIE signed 2021-06-21
LOOKER, ADAM signed 2021-07-21
HARRISON, CRISTIAN signed 2021-07-26
BLIGH, CAVAN MCKEON signed 2021-07-21
LAWS, STEPHEN W. signed 2021-07-21
GIACOMETTI, ROBERT DANIEL signed 2021-07-22
VERTEX PHARMACEUTICALS INCORPORATED BOSTON, MA65968/770PASDL, file of 2026-10-15

Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.